LU-177 PSMA

Clinical trials for LU-177 PSMA explained in plain language.

Never miss a new study

Get alerted when new LU-177 PSMA trials appear

Sign up with your email to follow new studies for LU-177 PSMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New study measures radioactive drug safety in vulnerable patients

Knowledge-focused Recruiting now

This study looks at how much of the radioactive drug Pluvicto reaches tumors and organs in patients whose kidneys or bone marrow are not working well. About 25 people will be enrolled to check for side effects and safety. The goal is to better understand dosing in these patients,…

Matched conditions: LU-177 PSMA

Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused

Last updated Jun 15, 2026 19:06 UTC

LU-177 PSMA

Get alerted when new LU-177 PSMA trials appear

New study measures radioactive drug safety in vulnerable patients